Ocugen, Inc. Operating Income Loss

• Ocugen, Inc. showed a decrease of -14.9% in Operating Income Loss from 2024 to 2025.
• This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
• XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 12 years of available data (2014 to 2025), Ocugen, Inc.'s Operating Income Loss has declined by 92.6%.
• Historical annual values: Fiscal year 2025: -$62.92 million | Fiscal year 2024: -$54.76 million | Fiscal year 2023: -$65.53 million | Fiscal year 2022: -$89.07 million | Fiscal year 2021: -$58.03 million | Fiscal year 2020: -$21.29 million | Fiscal year 2019: -$14.16 million | Fiscal year 2018: -$16.14 million | Fiscal year 2017: -$24.95 million | Fiscal year 2016: -$30.31 million | Fiscal year 2015: -$31.82 million | Fiscal year 2014: -$32.66 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026